Stock screenerAll disclosures →
EDGAR →
VRXA
Conviction 1Scan · Thu, Sep 3, 2026VRXA$1.38-1.43%
ResistanceSupportVol 14Insider buy2
Aug 18Aug 20Aug 24Aug 27Aug 31Sep 2
Veraxa Biotech AG - Post de-SPAC
Price1.38
Change-1.43%
Gap+1.43%
Rel volume1.01×
Avg volume177.97K
Avg $ vol286.44K
SMA 201.73
SMA 501.95
SMA 200—
Price vs 50-29.41%
Price vs 200—
MA stack—
50/200 cross—
Supertrenddown · 1.96
RSI (14)18
MACD hist0.11
MACD cross—
Stoch %K / %D15 / 12
ADX (14)59
+DI / −DI11 / 32
RSI divergenceBullish
MACD divergenceBearish
ATR %+21.98%
ADR %8.79%
52w high24.79
52w low1.35
From 52w high-94.43%
Above 52w low+2.22%
New 52w highNo
SqueezeOn · 32d
Bollinger width49.54%
%B0.09
Donchian pos15.07%
Donchian high2.00
Donchian low1.27
AVWAP (52w high)2.75
vs AVWAP high-49.84%
AVWAP (52w low)1.40
vs AVWAP low-1.45%
OBV trendDown
Chaikin MF (20)-0.31
Today vs 20d1.01×
Avg vol (14d)216.95K
Avg vol (20d)177.97K
Avg $ vol (20d)286.44K
Market cap—
RS 3m (vs SPY)—
RS 6m (vs SPY)—
RS line new highNo
Trend template—
Technical rank13.4
1 week-15.85%
1 month-23.33%
3 months—
6 months—
1 year—
YTD-94.43%
P/E—
P/B—
P/S—
P/FCF—
EPS—
Div yield—
ROE—
ROA—
Debt/Eq—
Current—
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth—
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value—
Revenue—
Net income—
Gross profit—
Free cash flow—
Industry—
ExchangeNasdaq
Shares out—
Employees—
Listed—
Free float—
Float %—
Short interest378.22K
Days to cover3.6d
Short volume21.4%
Squeeze score31 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction1 / 100
Pattern quality—
Tech rank13.4 / 100
Group rank—
Status laneNo active setup
Setup direction—
Pattern family
Resistance2.29
Support1.75
Days since event—
Candle confirm—
News sentiment—
Congress activity
Disclosed STOCK Act trades in VRXA
No recent disclosed trades by Congress in VRXA. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in VRXA · 2 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Antz Christoph Rudiger Chief Executive Officer · Ordinary Shares · 2026-08-27 | Buy | 5K | $8K | 2026-08-27 | 2026-08-31 |
Baumann Oliver Rolf Director · Ordinary Shares · 2026-08-27 | Buy | 50K | $75K | 2026-08-27 | 2026-08-31 |
SEC filings
EDGAR filings in VRXA · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.